Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.

Yang LiZhikai ZhuFuhai MaLiyan XueYantao Tian

Published in: Cancer medicine (2020)

In this study, GSRC patients with stage II-III experienced improved overall survival after receiving adjuvant CRT, which provides several treatment implications. More clinical trials will be needed to verify the conclusion derived from this study.

Keyphrases

clinical trial
early stage
randomized controlled trial
radiation therapy
squamous cell carcinoma
left ventricular
locally advanced
free survival
combination therapy